Table of contents

September 2017 - Volume 2 - 4


A

  1. Abergel, Armand

    1. Safety and efficacy of intra-arterial hepatic chemotherapy with doxorubicin-loaded nanoparticles in hepatocellular carcinoma
      Philippe Merle, Philippe Camus, Armand Abergel, Georges Philippe Pageaux, Claude Masliah, Jean Pierre Bronowicki, Jean Pierre Zarski, Gilles Pelletier, Mohamed Bouattour, Laetitia Farloux, Etienne Dorval, Gilles verset, Si-Nafa Si-Ahmed, Michel Doffoel, Patrice Couzigou, Julien Taieb, Bérangère Vasseur, Pierre Attali
  2. Agrawal, Bhuwnesh

    1. Key differences between 13 KRAS mutation detection technologies and their relevance for clinical practice
      James L Sherwood, Helen Brown, Alessandro Rettino, Amelie Schreieck, Graeme Clark, Bart Claes, Bhuwnesh Agrawal, Ria Chaston, Benjamin S G Kong, Paul Choppa, Anders O H Nygren, Ina L Deras, Alexander Kohlmann
  3. Attali, Pierre

    1. Safety and efficacy of intra-arterial hepatic chemotherapy with doxorubicin-loaded nanoparticles in hepatocellular carcinoma
      Philippe Merle, Philippe Camus, Armand Abergel, Georges Philippe Pageaux, Claude Masliah, Jean Pierre Bronowicki, Jean Pierre Zarski, Gilles Pelletier, Mohamed Bouattour, Laetitia Farloux, Etienne Dorval, Gilles verset, Si-Nafa Si-Ahmed, Michel Doffoel, Patrice Couzigou, Julien Taieb, Bérangère Vasseur, Pierre Attali

B

  1. Bakalos, Georgios

    1. Reply to ‘Biosimilars: a position paper of the European Society for Medical Oncology, with particular reference to oncology prescribers’
      Georgios Bakalos, Thomas Schreitmüller
  2. Bardelli, Alberto

    1. Genotyping tumour DNA in cerebrospinal fluid and plasma of a HER2-positive breast cancer patient with brain metastases
      Giulia Siravegna, Elena Geuna, Benedetta Mussolin, Giovanni Crisafulli, Alice Bartolini, Danilo Galizia, Laura Casorzo, Ivana Sarotto, Maurizio Scaltriti, Anna Sapino, Alberto Bardelli, Filippo Montemurro
  3. Bartolini, Alice

    1. Genotyping tumour DNA in cerebrospinal fluid and plasma of a HER2-positive breast cancer patient with brain metastases
      Giulia Siravegna, Elena Geuna, Benedetta Mussolin, Giovanni Crisafulli, Alice Bartolini, Danilo Galizia, Laura Casorzo, Ivana Sarotto, Maurizio Scaltriti, Anna Sapino, Alberto Bardelli, Filippo Montemurro
  4. Bielack, Stefan

    1. The care of adolescents and young adults with cancer: results of the ESMO/SIOPE survey
      Emmanouil Saloustros, Daniel P Stark, Kyriaki Michailidou, Giannis Mountzios, Laurence Brugieres, Fedro Alessandro Peccatori, Svetlana Jezdic, Samira Essiaf, Jean-Yves Douillard, Stefan Bielack
  5. Bisceglie, Maurizio Di

    1. Clinical outcome of patients with chemorefractory metastatic colorectal cancer treated with trifluridine/tipiracil (TAS-102): a single Italian institution compassionate use programme
      Vincenzo Sforza, Erika Martinelli, Claudia Cardone, Giulia Martini, Stefania Napolitano, Pietro Paolo Vitiello, Pasquale Vitale, Nicoletta Zanaletti, Alfonso Reginelli, Maurizio Di Bisceglie, Tiziana Pia Latiano, Anna Maria Bochicchio, Fabiana Cecere, Francesco Selvaggi, Fortunato Ciardiello, Teresa Troiani
  6. Bochicchio, Anna Maria

    1. Clinical outcome of patients with chemorefractory metastatic colorectal cancer treated with trifluridine/tipiracil (TAS-102): a single Italian institution compassionate use programme
      Vincenzo Sforza, Erika Martinelli, Claudia Cardone, Giulia Martini, Stefania Napolitano, Pietro Paolo Vitiello, Pasquale Vitale, Nicoletta Zanaletti, Alfonso Reginelli, Maurizio Di Bisceglie, Tiziana Pia Latiano, Anna Maria Bochicchio, Fabiana Cecere, Francesco Selvaggi, Fortunato Ciardiello, Teresa Troiani
  7. Bogaerts, Jan

    1. Detailed statistical assessment of the characteristics of the ESMO Magnitude of Clinical Benefit Scale (ESMO-MCBS) threshold rules
      Urania Dafni, Dimitris Karlis, Xanthi Pedeli, Jan Bogaerts, George Pentheroudakis, Josep Tabernero, Christoph C Zielinski, Martine J Piccart, Elisabeth G E de Vries, Nicola Jane Latino, Jean-Yves Douillard, Nathan I Cherny
  8. Bonaduce, Domenico

    1. Cardiotoxicity of immune checkpoint inhibitors
      Gilda Varricchi, Maria Rosaria Galdiero, Giancarlo Marone, Gjada Criscuolo, Maria Triassi, Domenico Bonaduce, Gianni Marone, Carlo Gabriele Tocchetti
  9. Bouattour, Mohamed

    1. Safety and efficacy of intra-arterial hepatic chemotherapy with doxorubicin-loaded nanoparticles in hepatocellular carcinoma
      Philippe Merle, Philippe Camus, Armand Abergel, Georges Philippe Pageaux, Claude Masliah, Jean Pierre Bronowicki, Jean Pierre Zarski, Gilles Pelletier, Mohamed Bouattour, Laetitia Farloux, Etienne Dorval, Gilles verset, Si-Nafa Si-Ahmed, Michel Doffoel, Patrice Couzigou, Julien Taieb, Bérangère Vasseur, Pierre Attali
  10. Braga, Sofia

    1. How many diseases is triple negative breast cancer: the protagonism of the immune microenvironment
      Diana P Saraiva, M Guadalupe Cabral, António Jacinto, Sofia Braga
  11. Brais, Rebecca

    1. Severe steroid-resistant anti-PD1 T-cell checkpoint inhibitor-induced hepatotoxicity driven by biliary injury
      Gary Joseph Doherty, Adam M Duckworth, Susan E Davies, George F Mells, Rebecca Brais, Susan V Harden, Christine A Parkinson, Pippa G Corrie
  12. Bronowicki, Jean Pierre

    1. Safety and efficacy of intra-arterial hepatic chemotherapy with doxorubicin-loaded nanoparticles in hepatocellular carcinoma
      Philippe Merle, Philippe Camus, Armand Abergel, Georges Philippe Pageaux, Claude Masliah, Jean Pierre Bronowicki, Jean Pierre Zarski, Gilles Pelletier, Mohamed Bouattour, Laetitia Farloux, Etienne Dorval, Gilles verset, Si-Nafa Si-Ahmed, Michel Doffoel, Patrice Couzigou, Julien Taieb, Bérangère Vasseur, Pierre Attali
  13. Brown, Helen

    1. Key differences between 13 KRAS mutation detection technologies and their relevance for clinical practice
      James L Sherwood, Helen Brown, Alessandro Rettino, Amelie Schreieck, Graeme Clark, Bart Claes, Bhuwnesh Agrawal, Ria Chaston, Benjamin S G Kong, Paul Choppa, Anders O H Nygren, Ina L Deras, Alexander Kohlmann
  14. Brugieres, Laurence

    1. The care of adolescents and young adults with cancer: results of the ESMO/SIOPE survey
      Emmanouil Saloustros, Daniel P Stark, Kyriaki Michailidou, Giannis Mountzios, Laurence Brugieres, Fedro Alessandro Peccatori, Svetlana Jezdic, Samira Essiaf, Jean-Yves Douillard, Stefan Bielack

C

  1. Camus, Philippe

    1. Safety and efficacy of intra-arterial hepatic chemotherapy with doxorubicin-loaded nanoparticles in hepatocellular carcinoma
      Philippe Merle, Philippe Camus, Armand Abergel, Georges Philippe Pageaux, Claude Masliah, Jean Pierre Bronowicki, Jean Pierre Zarski, Gilles Pelletier, Mohamed Bouattour, Laetitia Farloux, Etienne Dorval, Gilles verset, Si-Nafa Si-Ahmed, Michel Doffoel, Patrice Couzigou, Julien Taieb, Bérangère Vasseur, Pierre Attali
  2. Cardone, Claudia

    1. Clinical outcome of patients with chemorefractory metastatic colorectal cancer treated with trifluridine/tipiracil (TAS-102): a single Italian institution compassionate use programme
      Vincenzo Sforza, Erika Martinelli, Claudia Cardone, Giulia Martini, Stefania Napolitano, Pietro Paolo Vitiello, Pasquale Vitale, Nicoletta Zanaletti, Alfonso Reginelli, Maurizio Di Bisceglie, Tiziana Pia Latiano, Anna Maria Bochicchio, Fabiana Cecere, Francesco Selvaggi, Fortunato Ciardiello, Teresa Troiani
  3. Casorzo, Laura

    1. Genotyping tumour DNA in cerebrospinal fluid and plasma of a HER2-positive breast cancer patient with brain metastases
      Giulia Siravegna, Elena Geuna, Benedetta Mussolin, Giovanni Crisafulli, Alice Bartolini, Danilo Galizia, Laura Casorzo, Ivana Sarotto, Maurizio Scaltriti, Anna Sapino, Alberto Bardelli, Filippo Montemurro
  4. Cecere, Fabiana

    1. Clinical outcome of patients with chemorefractory metastatic colorectal cancer treated with trifluridine/tipiracil (TAS-102): a single Italian institution compassionate use programme
      Vincenzo Sforza, Erika Martinelli, Claudia Cardone, Giulia Martini, Stefania Napolitano, Pietro Paolo Vitiello, Pasquale Vitale, Nicoletta Zanaletti, Alfonso Reginelli, Maurizio Di Bisceglie, Tiziana Pia Latiano, Anna Maria Bochicchio, Fabiana Cecere, Francesco Selvaggi, Fortunato Ciardiello, Teresa Troiani
  5. Chan, Kelvin KW

    1. Do patients with reduced or excellent performance status derive the same clinical benefit from novel systemic cancer therapies? A systematic review and meta-analysis
      Sierra Cheng, Mahin Qureshi, Eleanor Pullenayegum, Adam Haynes, Kelvin KW Chan
  6. Chaston, Ria

    1. Key differences between 13 KRAS mutation detection technologies and their relevance for clinical practice
      James L Sherwood, Helen Brown, Alessandro Rettino, Amelie Schreieck, Graeme Clark, Bart Claes, Bhuwnesh Agrawal, Ria Chaston, Benjamin S G Kong, Paul Choppa, Anders O H Nygren, Ina L Deras, Alexander Kohlmann
  7. Chen, Li

    1. Palliative treatment with radiation-emitting metallic stents in unresectable Bismuth type III or IV hilar cholangiocarcinoma
      Jian Lu, Jin-He Guo, Hai-Dong Zhu, Guang-Yu Zhu, Yong Wang, Qi Zhang, Li Chen, Chao Wang, Tian-Fan Pan, Gao-Jun Teng
  8. Cheng, Sierra

    1. Do patients with reduced or excellent performance status derive the same clinical benefit from novel systemic cancer therapies? A systematic review and meta-analysis
      Sierra Cheng, Mahin Qureshi, Eleanor Pullenayegum, Adam Haynes, Kelvin KW Chan
  9. Cherny, Nathan I

    1. Detailed statistical assessment of the characteristics of the ESMO Magnitude of Clinical Benefit Scale (ESMO-MCBS) threshold rules
      Urania Dafni, Dimitris Karlis, Xanthi Pedeli, Jan Bogaerts, George Pentheroudakis, Josep Tabernero, Christoph C Zielinski, Martine J Piccart, Elisabeth G E de Vries, Nicola Jane Latino, Jean-Yves Douillard, Nathan I Cherny
  10. Choppa, Paul

    1. Key differences between 13 KRAS mutation detection technologies and their relevance for clinical practice
      James L Sherwood, Helen Brown, Alessandro Rettino, Amelie Schreieck, Graeme Clark, Bart Claes, Bhuwnesh Agrawal, Ria Chaston, Benjamin S G Kong, Paul Choppa, Anders O H Nygren, Ina L Deras, Alexander Kohlmann
  11. Ciardiello, Fortunato

    1. Clinical outcome of patients with chemorefractory metastatic colorectal cancer treated with trifluridine/tipiracil (TAS-102): a single Italian institution compassionate use programme
      Vincenzo Sforza, Erika Martinelli, Claudia Cardone, Giulia Martini, Stefania Napolitano, Pietro Paolo Vitiello, Pasquale Vitale, Nicoletta Zanaletti, Alfonso Reginelli, Maurizio Di Bisceglie, Tiziana Pia Latiano, Anna Maria Bochicchio, Fabiana Cecere, Francesco Selvaggi, Fortunato Ciardiello, Teresa Troiani
  12. Claes, Bart

    1. Key differences between 13 KRAS mutation detection technologies and their relevance for clinical practice
      James L Sherwood, Helen Brown, Alessandro Rettino, Amelie Schreieck, Graeme Clark, Bart Claes, Bhuwnesh Agrawal, Ria Chaston, Benjamin S G Kong, Paul Choppa, Anders O H Nygren, Ina L Deras, Alexander Kohlmann
  13. Clark, Graeme

    1. Key differences between 13 KRAS mutation detection technologies and their relevance for clinical practice
      James L Sherwood, Helen Brown, Alessandro Rettino, Amelie Schreieck, Graeme Clark, Bart Claes, Bhuwnesh Agrawal, Ria Chaston, Benjamin S G Kong, Paul Choppa, Anders O H Nygren, Ina L Deras, Alexander Kohlmann
  14. Corrie, Pippa G

    1. Severe steroid-resistant anti-PD1 T-cell checkpoint inhibitor-induced hepatotoxicity driven by biliary injury
      Gary Joseph Doherty, Adam M Duckworth, Susan E Davies, George F Mells, Rebecca Brais, Susan V Harden, Christine A Parkinson, Pippa G Corrie
  15. Couzigou, Patrice

    1. Safety and efficacy of intra-arterial hepatic chemotherapy with doxorubicin-loaded nanoparticles in hepatocellular carcinoma
      Philippe Merle, Philippe Camus, Armand Abergel, Georges Philippe Pageaux, Claude Masliah, Jean Pierre Bronowicki, Jean Pierre Zarski, Gilles Pelletier, Mohamed Bouattour, Laetitia Farloux, Etienne Dorval, Gilles verset, Si-Nafa Si-Ahmed, Michel Doffoel, Patrice Couzigou, Julien Taieb, Bérangère Vasseur, Pierre Attali
  16. Crisafulli, Giovanni

    1. Genotyping tumour DNA in cerebrospinal fluid and plasma of a HER2-positive breast cancer patient with brain metastases
      Giulia Siravegna, Elena Geuna, Benedetta Mussolin, Giovanni Crisafulli, Alice Bartolini, Danilo Galizia, Laura Casorzo, Ivana Sarotto, Maurizio Scaltriti, Anna Sapino, Alberto Bardelli, Filippo Montemurro
  17. Criscuolo, Gjada

    1. Cardiotoxicity of immune checkpoint inhibitors
      Gilda Varricchi, Maria Rosaria Galdiero, Giancarlo Marone, Gjada Criscuolo, Maria Triassi, Domenico Bonaduce, Gianni Marone, Carlo Gabriele Tocchetti

D

  1. Dafni, Urania

    1. Detailed statistical assessment of the characteristics of the ESMO Magnitude of Clinical Benefit Scale (ESMO-MCBS) threshold rules
      Urania Dafni, Dimitris Karlis, Xanthi Pedeli, Jan Bogaerts, George Pentheroudakis, Josep Tabernero, Christoph C Zielinski, Martine J Piccart, Elisabeth G E de Vries, Nicola Jane Latino, Jean-Yves Douillard, Nathan I Cherny
  2. Davies, Susan E

    1. Severe steroid-resistant anti-PD1 T-cell checkpoint inhibitor-induced hepatotoxicity driven by biliary injury
      Gary Joseph Doherty, Adam M Duckworth, Susan E Davies, George F Mells, Rebecca Brais, Susan V Harden, Christine A Parkinson, Pippa G Corrie
  3. De Mattos-Arruda, Leticia

    1. Liquid biopsy for HER2-positive breast cancer brain metastasis: the role of the cerebrospinal fluid
      Leticia De Mattos-Arruda
  4. Deras, Ina L

    1. Key differences between 13 KRAS mutation detection technologies and their relevance for clinical practice
      James L Sherwood, Helen Brown, Alessandro Rettino, Amelie Schreieck, Graeme Clark, Bart Claes, Bhuwnesh Agrawal, Ria Chaston, Benjamin S G Kong, Paul Choppa, Anders O H Nygren, Ina L Deras, Alexander Kohlmann
  5. Doffoel, Michel

    1. Safety and efficacy of intra-arterial hepatic chemotherapy with doxorubicin-loaded nanoparticles in hepatocellular carcinoma
      Philippe Merle, Philippe Camus, Armand Abergel, Georges Philippe Pageaux, Claude Masliah, Jean Pierre Bronowicki, Jean Pierre Zarski, Gilles Pelletier, Mohamed Bouattour, Laetitia Farloux, Etienne Dorval, Gilles verset, Si-Nafa Si-Ahmed, Michel Doffoel, Patrice Couzigou, Julien Taieb, Bérangère Vasseur, Pierre Attali
  6. Doherty, Gary Joseph

    1. Severe steroid-resistant anti-PD1 T-cell checkpoint inhibitor-induced hepatotoxicity driven by biliary injury
      Gary Joseph Doherty, Adam M Duckworth, Susan E Davies, George F Mells, Rebecca Brais, Susan V Harden, Christine A Parkinson, Pippa G Corrie
  7. Dorval, Etienne

    1. Safety and efficacy of intra-arterial hepatic chemotherapy with doxorubicin-loaded nanoparticles in hepatocellular carcinoma
      Philippe Merle, Philippe Camus, Armand Abergel, Georges Philippe Pageaux, Claude Masliah, Jean Pierre Bronowicki, Jean Pierre Zarski, Gilles Pelletier, Mohamed Bouattour, Laetitia Farloux, Etienne Dorval, Gilles verset, Si-Nafa Si-Ahmed, Michel Doffoel, Patrice Couzigou, Julien Taieb, Bérangère Vasseur, Pierre Attali
  8. Douillard, Jean-Yves

    1. The care of adolescents and young adults with cancer: results of the ESMO/SIOPE survey
      Emmanouil Saloustros, Daniel P Stark, Kyriaki Michailidou, Giannis Mountzios, Laurence Brugieres, Fedro Alessandro Peccatori, Svetlana Jezdic, Samira Essiaf, Jean-Yves Douillard, Stefan Bielack
    2. Detailed statistical assessment of the characteristics of the ESMO Magnitude of Clinical Benefit Scale (ESMO-MCBS) threshold rules
      Urania Dafni, Dimitris Karlis, Xanthi Pedeli, Jan Bogaerts, George Pentheroudakis, Josep Tabernero, Christoph C Zielinski, Martine J Piccart, Elisabeth G E de Vries, Nicola Jane Latino, Jean-Yves Douillard, Nathan I Cherny
  9. Duckworth, Adam M

    1. Severe steroid-resistant anti-PD1 T-cell checkpoint inhibitor-induced hepatotoxicity driven by biliary injury
      Gary Joseph Doherty, Adam M Duckworth, Susan E Davies, George F Mells, Rebecca Brais, Susan V Harden, Christine A Parkinson, Pippa G Corrie

E

  1. Essiaf, Samira

    1. The care of adolescents and young adults with cancer: results of the ESMO/SIOPE survey
      Emmanouil Saloustros, Daniel P Stark, Kyriaki Michailidou, Giannis Mountzios, Laurence Brugieres, Fedro Alessandro Peccatori, Svetlana Jezdic, Samira Essiaf, Jean-Yves Douillard, Stefan Bielack

F

  1. Farloux, Laetitia

    1. Safety and efficacy of intra-arterial hepatic chemotherapy with doxorubicin-loaded nanoparticles in hepatocellular carcinoma
      Philippe Merle, Philippe Camus, Armand Abergel, Georges Philippe Pageaux, Claude Masliah, Jean Pierre Bronowicki, Jean Pierre Zarski, Gilles Pelletier, Mohamed Bouattour, Laetitia Farloux, Etienne Dorval, Gilles verset, Si-Nafa Si-Ahmed, Michel Doffoel, Patrice Couzigou, Julien Taieb, Bérangère Vasseur, Pierre Attali
  2. Fehrmann, Rudolf S

    1. Indispensable benefit of independent investigator-driven research in a changing clinical trial landscape
      Sjoukje F Oosting, Rudolf S Fehrmann, Elisabeth G E de Vries

G

  1. Galdiero, Maria Rosaria

    1. Cardiotoxicity of immune checkpoint inhibitors
      Gilda Varricchi, Maria Rosaria Galdiero, Giancarlo Marone, Gjada Criscuolo, Maria Triassi, Domenico Bonaduce, Gianni Marone, Carlo Gabriele Tocchetti
  2. Galizia, Danilo

    1. Genotyping tumour DNA in cerebrospinal fluid and plasma of a HER2-positive breast cancer patient with brain metastases
      Giulia Siravegna, Elena Geuna, Benedetta Mussolin, Giovanni Crisafulli, Alice Bartolini, Danilo Galizia, Laura Casorzo, Ivana Sarotto, Maurizio Scaltriti, Anna Sapino, Alberto Bardelli, Filippo Montemurro
  3. Geuna, Elena

    1. Genotyping tumour DNA in cerebrospinal fluid and plasma of a HER2-positive breast cancer patient with brain metastases
      Giulia Siravegna, Elena Geuna, Benedetta Mussolin, Giovanni Crisafulli, Alice Bartolini, Danilo Galizia, Laura Casorzo, Ivana Sarotto, Maurizio Scaltriti, Anna Sapino, Alberto Bardelli, Filippo Montemurro
  4. Goto, Yasushi

    1. Continuing EGFR-TKI beyond radiological progression in patients with advanced or recurrent, EGFR mutation-positive non-small-cell lung cancer: an observational study
      Yasushi Goto, Chiharu Tanai, Kiyotaka Yoh, Yukio Hosomi, Hiroshi Sakai, Terufumi Kato, Takayuki Kaburagi, Makoto Nishio, Young Hak Kim, Akira Inoue, Yoshinori Hasegawa, Hiroshi Isobe, Yoshio Tomizawa, Yoshiaki Mori, Koichi Minato, Kazuhiko Yamada, Yasuo Ohashi, Hideo Kunitoh
  5. Guadalupe Cabral, M

    1. How many diseases is triple negative breast cancer: the protagonism of the immune microenvironment
      Diana P Saraiva, M Guadalupe Cabral, António Jacinto, Sofia Braga
  6. Guo, Jin-He

    1. Palliative treatment with radiation-emitting metallic stents in unresectable Bismuth type III or IV hilar cholangiocarcinoma
      Jian Lu, Jin-He Guo, Hai-Dong Zhu, Guang-Yu Zhu, Yong Wang, Qi Zhang, Li Chen, Chao Wang, Tian-Fan Pan, Gao-Jun Teng

H

  1. Harden, Susan V

    1. Severe steroid-resistant anti-PD1 T-cell checkpoint inhibitor-induced hepatotoxicity driven by biliary injury
      Gary Joseph Doherty, Adam M Duckworth, Susan E Davies, George F Mells, Rebecca Brais, Susan V Harden, Christine A Parkinson, Pippa G Corrie
  2. Hasegawa, Yoshinori

    1. Continuing EGFR-TKI beyond radiological progression in patients with advanced or recurrent, EGFR mutation-positive non-small-cell lung cancer: an observational study
      Yasushi Goto, Chiharu Tanai, Kiyotaka Yoh, Yukio Hosomi, Hiroshi Sakai, Terufumi Kato, Takayuki Kaburagi, Makoto Nishio, Young Hak Kim, Akira Inoue, Yoshinori Hasegawa, Hiroshi Isobe, Yoshio Tomizawa, Yoshiaki Mori, Koichi Minato, Kazuhiko Yamada, Yasuo Ohashi, Hideo Kunitoh
  3. Haynes, Adam

    1. Do patients with reduced or excellent performance status derive the same clinical benefit from novel systemic cancer therapies? A systematic review and meta-analysis
      Sierra Cheng, Mahin Qureshi, Eleanor Pullenayegum, Adam Haynes, Kelvin KW Chan
  4. Hosomi, Yukio

    1. Continuing EGFR-TKI beyond radiological progression in patients with advanced or recurrent, EGFR mutation-positive non-small-cell lung cancer: an observational study
      Yasushi Goto, Chiharu Tanai, Kiyotaka Yoh, Yukio Hosomi, Hiroshi Sakai, Terufumi Kato, Takayuki Kaburagi, Makoto Nishio, Young Hak Kim, Akira Inoue, Yoshinori Hasegawa, Hiroshi Isobe, Yoshio Tomizawa, Yoshiaki Mori, Koichi Minato, Kazuhiko Yamada, Yasuo Ohashi, Hideo Kunitoh

I

  1. Inoue, Akira

    1. Continuing EGFR-TKI beyond radiological progression in patients with advanced or recurrent, EGFR mutation-positive non-small-cell lung cancer: an observational study
      Yasushi Goto, Chiharu Tanai, Kiyotaka Yoh, Yukio Hosomi, Hiroshi Sakai, Terufumi Kato, Takayuki Kaburagi, Makoto Nishio, Young Hak Kim, Akira Inoue, Yoshinori Hasegawa, Hiroshi Isobe, Yoshio Tomizawa, Yoshiaki Mori, Koichi Minato, Kazuhiko Yamada, Yasuo Ohashi, Hideo Kunitoh
  2. Isobe, Hiroshi

    1. Continuing EGFR-TKI beyond radiological progression in patients with advanced or recurrent, EGFR mutation-positive non-small-cell lung cancer: an observational study
      Yasushi Goto, Chiharu Tanai, Kiyotaka Yoh, Yukio Hosomi, Hiroshi Sakai, Terufumi Kato, Takayuki Kaburagi, Makoto Nishio, Young Hak Kim, Akira Inoue, Yoshinori Hasegawa, Hiroshi Isobe, Yoshio Tomizawa, Yoshiaki Mori, Koichi Minato, Kazuhiko Yamada, Yasuo Ohashi, Hideo Kunitoh

J

  1. Jacinto, António

    1. How many diseases is triple negative breast cancer: the protagonism of the immune microenvironment
      Diana P Saraiva, M Guadalupe Cabral, António Jacinto, Sofia Braga
  2. Jezdic, Svetlana

    1. The care of adolescents and young adults with cancer: results of the ESMO/SIOPE survey
      Emmanouil Saloustros, Daniel P Stark, Kyriaki Michailidou, Giannis Mountzios, Laurence Brugieres, Fedro Alessandro Peccatori, Svetlana Jezdic, Samira Essiaf, Jean-Yves Douillard, Stefan Bielack

K

  1. Kaburagi, Takayuki

    1. Continuing EGFR-TKI beyond radiological progression in patients with advanced or recurrent, EGFR mutation-positive non-small-cell lung cancer: an observational study
      Yasushi Goto, Chiharu Tanai, Kiyotaka Yoh, Yukio Hosomi, Hiroshi Sakai, Terufumi Kato, Takayuki Kaburagi, Makoto Nishio, Young Hak Kim, Akira Inoue, Yoshinori Hasegawa, Hiroshi Isobe, Yoshio Tomizawa, Yoshiaki Mori, Koichi Minato, Kazuhiko Yamada, Yasuo Ohashi, Hideo Kunitoh
  2. Kapodistrias, Nikos

    1. Nivolumab-induced hypothyroidism and selective pituitary insufficiency in a patient with lung adenocarcinoma: a case report and review of the literature
      Myrto Kastrisiou, Fereniki-Lida Kostadima, Aristides Kefas, George Zarkavelis, Nikos Kapodistrias, Evangelos Ntouvelis, Dimitrios Petrakis, Alexandra Papadaki, Amalia Vassou, George Pentheroudakis
  3. Karlis, Dimitris

    1. Detailed statistical assessment of the characteristics of the ESMO Magnitude of Clinical Benefit Scale (ESMO-MCBS) threshold rules
      Urania Dafni, Dimitris Karlis, Xanthi Pedeli, Jan Bogaerts, George Pentheroudakis, Josep Tabernero, Christoph C Zielinski, Martine J Piccart, Elisabeth G E de Vries, Nicola Jane Latino, Jean-Yves Douillard, Nathan I Cherny
  4. Kastrisiou, Myrto

    1. Nivolumab-induced hypothyroidism and selective pituitary insufficiency in a patient with lung adenocarcinoma: a case report and review of the literature
      Myrto Kastrisiou, Fereniki-Lida Kostadima, Aristides Kefas, George Zarkavelis, Nikos Kapodistrias, Evangelos Ntouvelis, Dimitrios Petrakis, Alexandra Papadaki, Amalia Vassou, George Pentheroudakis
  5. Kato, Terufumi

    1. Continuing EGFR-TKI beyond radiological progression in patients with advanced or recurrent, EGFR mutation-positive non-small-cell lung cancer: an observational study
      Yasushi Goto, Chiharu Tanai, Kiyotaka Yoh, Yukio Hosomi, Hiroshi Sakai, Terufumi Kato, Takayuki Kaburagi, Makoto Nishio, Young Hak Kim, Akira Inoue, Yoshinori Hasegawa, Hiroshi Isobe, Yoshio Tomizawa, Yoshiaki Mori, Koichi Minato, Kazuhiko Yamada, Yasuo Ohashi, Hideo Kunitoh
  6. Kefas, Aristides

    1. Nivolumab-induced hypothyroidism and selective pituitary insufficiency in a patient with lung adenocarcinoma: a case report and review of the literature
      Myrto Kastrisiou, Fereniki-Lida Kostadima, Aristides Kefas, George Zarkavelis, Nikos Kapodistrias, Evangelos Ntouvelis, Dimitrios Petrakis, Alexandra Papadaki, Amalia Vassou, George Pentheroudakis
  7. Kim, Young Hak

    1. Continuing EGFR-TKI beyond radiological progression in patients with advanced or recurrent, EGFR mutation-positive non-small-cell lung cancer: an observational study
      Yasushi Goto, Chiharu Tanai, Kiyotaka Yoh, Yukio Hosomi, Hiroshi Sakai, Terufumi Kato, Takayuki Kaburagi, Makoto Nishio, Young Hak Kim, Akira Inoue, Yoshinori Hasegawa, Hiroshi Isobe, Yoshio Tomizawa, Yoshiaki Mori, Koichi Minato, Kazuhiko Yamada, Yasuo Ohashi, Hideo Kunitoh
  8. Kohlmann, Alexander

    1. Key differences between 13 KRAS mutation detection technologies and their relevance for clinical practice
      James L Sherwood, Helen Brown, Alessandro Rettino, Amelie Schreieck, Graeme Clark, Bart Claes, Bhuwnesh Agrawal, Ria Chaston, Benjamin S G Kong, Paul Choppa, Anders O H Nygren, Ina L Deras, Alexander Kohlmann
  9. Kong, Benjamin S G

    1. Key differences between 13 KRAS mutation detection technologies and their relevance for clinical practice
      James L Sherwood, Helen Brown, Alessandro Rettino, Amelie Schreieck, Graeme Clark, Bart Claes, Bhuwnesh Agrawal, Ria Chaston, Benjamin S G Kong, Paul Choppa, Anders O H Nygren, Ina L Deras, Alexander Kohlmann
  10. Kostadima, Fereniki-Lida

    1. Nivolumab-induced hypothyroidism and selective pituitary insufficiency in a patient with lung adenocarcinoma: a case report and review of the literature
      Myrto Kastrisiou, Fereniki-Lida Kostadima, Aristides Kefas, George Zarkavelis, Nikos Kapodistrias, Evangelos Ntouvelis, Dimitrios Petrakis, Alexandra Papadaki, Amalia Vassou, George Pentheroudakis
  11. Koutsoukou, Antonia

    1. Admission of critically ill patients with cancer to the ICU: many uncertainties remain
      Antonia Koutsoukou
  12. Kunitoh, Hideo

    1. Continuing EGFR-TKI beyond radiological progression in patients with advanced or recurrent, EGFR mutation-positive non-small-cell lung cancer: an observational study
      Yasushi Goto, Chiharu Tanai, Kiyotaka Yoh, Yukio Hosomi, Hiroshi Sakai, Terufumi Kato, Takayuki Kaburagi, Makoto Nishio, Young Hak Kim, Akira Inoue, Yoshinori Hasegawa, Hiroshi Isobe, Yoshio Tomizawa, Yoshiaki Mori, Koichi Minato, Kazuhiko Yamada, Yasuo Ohashi, Hideo Kunitoh

L

  1. Latiano, Tiziana Pia

    1. Clinical outcome of patients with chemorefractory metastatic colorectal cancer treated with trifluridine/tipiracil (TAS-102): a single Italian institution compassionate use programme
      Vincenzo Sforza, Erika Martinelli, Claudia Cardone, Giulia Martini, Stefania Napolitano, Pietro Paolo Vitiello, Pasquale Vitale, Nicoletta Zanaletti, Alfonso Reginelli, Maurizio Di Bisceglie, Tiziana Pia Latiano, Anna Maria Bochicchio, Fabiana Cecere, Francesco Selvaggi, Fortunato Ciardiello, Teresa Troiani
  2. Latino, Nicola Jane

    1. Detailed statistical assessment of the characteristics of the ESMO Magnitude of Clinical Benefit Scale (ESMO-MCBS) threshold rules
      Urania Dafni, Dimitris Karlis, Xanthi Pedeli, Jan Bogaerts, George Pentheroudakis, Josep Tabernero, Christoph C Zielinski, Martine J Piccart, Elisabeth G E de Vries, Nicola Jane Latino, Jean-Yves Douillard, Nathan I Cherny
  3. Lu, Jian

    1. Palliative treatment with radiation-emitting metallic stents in unresectable Bismuth type III or IV hilar cholangiocarcinoma
      Jian Lu, Jin-He Guo, Hai-Dong Zhu, Guang-Yu Zhu, Yong Wang, Qi Zhang, Li Chen, Chao Wang, Tian-Fan Pan, Gao-Jun Teng

M

  1. Marone, Giancarlo

    1. Cardiotoxicity of immune checkpoint inhibitors
      Gilda Varricchi, Maria Rosaria Galdiero, Giancarlo Marone, Gjada Criscuolo, Maria Triassi, Domenico Bonaduce, Gianni Marone, Carlo Gabriele Tocchetti
  2. Marone, Gianni

    1. Cardiotoxicity of immune checkpoint inhibitors
      Gilda Varricchi, Maria Rosaria Galdiero, Giancarlo Marone, Gjada Criscuolo, Maria Triassi, Domenico Bonaduce, Gianni Marone, Carlo Gabriele Tocchetti
  3. Martinelli, Erika

    1. Clinical outcome of patients with chemorefractory metastatic colorectal cancer treated with trifluridine/tipiracil (TAS-102): a single Italian institution compassionate use programme
      Vincenzo Sforza, Erika Martinelli, Claudia Cardone, Giulia Martini, Stefania Napolitano, Pietro Paolo Vitiello, Pasquale Vitale, Nicoletta Zanaletti, Alfonso Reginelli, Maurizio Di Bisceglie, Tiziana Pia Latiano, Anna Maria Bochicchio, Fabiana Cecere, Francesco Selvaggi, Fortunato Ciardiello, Teresa Troiani
  4. Martini, Giulia

    1. Clinical outcome of patients with chemorefractory metastatic colorectal cancer treated with trifluridine/tipiracil (TAS-102): a single Italian institution compassionate use programme
      Vincenzo Sforza, Erika Martinelli, Claudia Cardone, Giulia Martini, Stefania Napolitano, Pietro Paolo Vitiello, Pasquale Vitale, Nicoletta Zanaletti, Alfonso Reginelli, Maurizio Di Bisceglie, Tiziana Pia Latiano, Anna Maria Bochicchio, Fabiana Cecere, Francesco Selvaggi, Fortunato Ciardiello, Teresa Troiani
  5. Masliah, Claude

    1. Safety and efficacy of intra-arterial hepatic chemotherapy with doxorubicin-loaded nanoparticles in hepatocellular carcinoma
      Philippe Merle, Philippe Camus, Armand Abergel, Georges Philippe Pageaux, Claude Masliah, Jean Pierre Bronowicki, Jean Pierre Zarski, Gilles Pelletier, Mohamed Bouattour, Laetitia Farloux, Etienne Dorval, Gilles verset, Si-Nafa Si-Ahmed, Michel Doffoel, Patrice Couzigou, Julien Taieb, Bérangère Vasseur, Pierre Attali
  6. Mells, George F

    1. Severe steroid-resistant anti-PD1 T-cell checkpoint inhibitor-induced hepatotoxicity driven by biliary injury
      Gary Joseph Doherty, Adam M Duckworth, Susan E Davies, George F Mells, Rebecca Brais, Susan V Harden, Christine A Parkinson, Pippa G Corrie
  7. Merle, Philippe

    1. Safety and efficacy of intra-arterial hepatic chemotherapy with doxorubicin-loaded nanoparticles in hepatocellular carcinoma
      Philippe Merle, Philippe Camus, Armand Abergel, Georges Philippe Pageaux, Claude Masliah, Jean Pierre Bronowicki, Jean Pierre Zarski, Gilles Pelletier, Mohamed Bouattour, Laetitia Farloux, Etienne Dorval, Gilles verset, Si-Nafa Si-Ahmed, Michel Doffoel, Patrice Couzigou, Julien Taieb, Bérangère Vasseur, Pierre Attali
  8. Michailidou, Kyriaki

    1. The care of adolescents and young adults with cancer: results of the ESMO/SIOPE survey
      Emmanouil Saloustros, Daniel P Stark, Kyriaki Michailidou, Giannis Mountzios, Laurence Brugieres, Fedro Alessandro Peccatori, Svetlana Jezdic, Samira Essiaf, Jean-Yves Douillard, Stefan Bielack
  9. Minato, Koichi

    1. Continuing EGFR-TKI beyond radiological progression in patients with advanced or recurrent, EGFR mutation-positive non-small-cell lung cancer: an observational study
      Yasushi Goto, Chiharu Tanai, Kiyotaka Yoh, Yukio Hosomi, Hiroshi Sakai, Terufumi Kato, Takayuki Kaburagi, Makoto Nishio, Young Hak Kim, Akira Inoue, Yoshinori Hasegawa, Hiroshi Isobe, Yoshio Tomizawa, Yoshiaki Mori, Koichi Minato, Kazuhiko Yamada, Yasuo Ohashi, Hideo Kunitoh
  10. Montemurro, Filippo

    1. Genotyping tumour DNA in cerebrospinal fluid and plasma of a HER2-positive breast cancer patient with brain metastases
      Giulia Siravegna, Elena Geuna, Benedetta Mussolin, Giovanni Crisafulli, Alice Bartolini, Danilo Galizia, Laura Casorzo, Ivana Sarotto, Maurizio Scaltriti, Anna Sapino, Alberto Bardelli, Filippo Montemurro
  11. Mori, Yoshiaki

    1. Continuing EGFR-TKI beyond radiological progression in patients with advanced or recurrent, EGFR mutation-positive non-small-cell lung cancer: an observational study
      Yasushi Goto, Chiharu Tanai, Kiyotaka Yoh, Yukio Hosomi, Hiroshi Sakai, Terufumi Kato, Takayuki Kaburagi, Makoto Nishio, Young Hak Kim, Akira Inoue, Yoshinori Hasegawa, Hiroshi Isobe, Yoshio Tomizawa, Yoshiaki Mori, Koichi Minato, Kazuhiko Yamada, Yasuo Ohashi, Hideo Kunitoh
  12. Mountzios, Giannis

    1. The care of adolescents and young adults with cancer: results of the ESMO/SIOPE survey
      Emmanouil Saloustros, Daniel P Stark, Kyriaki Michailidou, Giannis Mountzios, Laurence Brugieres, Fedro Alessandro Peccatori, Svetlana Jezdic, Samira Essiaf, Jean-Yves Douillard, Stefan Bielack
  13. Mussolin, Benedetta

    1. Genotyping tumour DNA in cerebrospinal fluid and plasma of a HER2-positive breast cancer patient with brain metastases
      Giulia Siravegna, Elena Geuna, Benedetta Mussolin, Giovanni Crisafulli, Alice Bartolini, Danilo Galizia, Laura Casorzo, Ivana Sarotto, Maurizio Scaltriti, Anna Sapino, Alberto Bardelli, Filippo Montemurro

N

  1. Napolitano, Stefania

    1. Clinical outcome of patients with chemorefractory metastatic colorectal cancer treated with trifluridine/tipiracil (TAS-102): a single Italian institution compassionate use programme
      Vincenzo Sforza, Erika Martinelli, Claudia Cardone, Giulia Martini, Stefania Napolitano, Pietro Paolo Vitiello, Pasquale Vitale, Nicoletta Zanaletti, Alfonso Reginelli, Maurizio Di Bisceglie, Tiziana Pia Latiano, Anna Maria Bochicchio, Fabiana Cecere, Francesco Selvaggi, Fortunato Ciardiello, Teresa Troiani
  2. Nishio, Makoto

    1. Continuing EGFR-TKI beyond radiological progression in patients with advanced or recurrent, EGFR mutation-positive non-small-cell lung cancer: an observational study
      Yasushi Goto, Chiharu Tanai, Kiyotaka Yoh, Yukio Hosomi, Hiroshi Sakai, Terufumi Kato, Takayuki Kaburagi, Makoto Nishio, Young Hak Kim, Akira Inoue, Yoshinori Hasegawa, Hiroshi Isobe, Yoshio Tomizawa, Yoshiaki Mori, Koichi Minato, Kazuhiko Yamada, Yasuo Ohashi, Hideo Kunitoh
  3. Ntouvelis, Evangelos

    1. Nivolumab-induced hypothyroidism and selective pituitary insufficiency in a patient with lung adenocarcinoma: a case report and review of the literature
      Myrto Kastrisiou, Fereniki-Lida Kostadima, Aristides Kefas, George Zarkavelis, Nikos Kapodistrias, Evangelos Ntouvelis, Dimitrios Petrakis, Alexandra Papadaki, Amalia Vassou, George Pentheroudakis
  4. Nygren, Anders O H

    1. Key differences between 13 KRAS mutation detection technologies and their relevance for clinical practice
      James L Sherwood, Helen Brown, Alessandro Rettino, Amelie Schreieck, Graeme Clark, Bart Claes, Bhuwnesh Agrawal, Ria Chaston, Benjamin S G Kong, Paul Choppa, Anders O H Nygren, Ina L Deras, Alexander Kohlmann

O

  1. Ohashi, Yasuo

    1. Continuing EGFR-TKI beyond radiological progression in patients with advanced or recurrent, EGFR mutation-positive non-small-cell lung cancer: an observational study
      Yasushi Goto, Chiharu Tanai, Kiyotaka Yoh, Yukio Hosomi, Hiroshi Sakai, Terufumi Kato, Takayuki Kaburagi, Makoto Nishio, Young Hak Kim, Akira Inoue, Yoshinori Hasegawa, Hiroshi Isobe, Yoshio Tomizawa, Yoshiaki Mori, Koichi Minato, Kazuhiko Yamada, Yasuo Ohashi, Hideo Kunitoh
  2. Oosting, Sjoukje F

    1. Indispensable benefit of independent investigator-driven research in a changing clinical trial landscape
      Sjoukje F Oosting, Rudolf S Fehrmann, Elisabeth G E de Vries
  3. Opdam, Frans L

    1. TAS-102 and the quest for predictive biomarkers
      Daphne L van der Velden, Frans L Opdam, Frans L Opdam
    2. TAS-102 and the quest for predictive biomarkers
      Daphne L van der Velden, Frans L Opdam, Frans L Opdam

P

  1. Pageaux, Georges Philippe

    1. Safety and efficacy of intra-arterial hepatic chemotherapy with doxorubicin-loaded nanoparticles in hepatocellular carcinoma
      Philippe Merle, Philippe Camus, Armand Abergel, Georges Philippe Pageaux, Claude Masliah, Jean Pierre Bronowicki, Jean Pierre Zarski, Gilles Pelletier, Mohamed Bouattour, Laetitia Farloux, Etienne Dorval, Gilles verset, Si-Nafa Si-Ahmed, Michel Doffoel, Patrice Couzigou, Julien Taieb, Bérangère Vasseur, Pierre Attali
  2. Pan, Tian-Fan

    1. Palliative treatment with radiation-emitting metallic stents in unresectable Bismuth type III or IV hilar cholangiocarcinoma
      Jian Lu, Jin-He Guo, Hai-Dong Zhu, Guang-Yu Zhu, Yong Wang, Qi Zhang, Li Chen, Chao Wang, Tian-Fan Pan, Gao-Jun Teng
  3. Papadaki, Alexandra

    1. Nivolumab-induced hypothyroidism and selective pituitary insufficiency in a patient with lung adenocarcinoma: a case report and review of the literature
      Myrto Kastrisiou, Fereniki-Lida Kostadima, Aristides Kefas, George Zarkavelis, Nikos Kapodistrias, Evangelos Ntouvelis, Dimitrios Petrakis, Alexandra Papadaki, Amalia Vassou, George Pentheroudakis
  4. Parkinson, Christine A

    1. Severe steroid-resistant anti-PD1 T-cell checkpoint inhibitor-induced hepatotoxicity driven by biliary injury
      Gary Joseph Doherty, Adam M Duckworth, Susan E Davies, George F Mells, Rebecca Brais, Susan V Harden, Christine A Parkinson, Pippa G Corrie
  5. Peccatori, Fedro Alessandro

    1. The care of adolescents and young adults with cancer: results of the ESMO/SIOPE survey
      Emmanouil Saloustros, Daniel P Stark, Kyriaki Michailidou, Giannis Mountzios, Laurence Brugieres, Fedro Alessandro Peccatori, Svetlana Jezdic, Samira Essiaf, Jean-Yves Douillard, Stefan Bielack
  6. Pedeli, Xanthi

    1. Detailed statistical assessment of the characteristics of the ESMO Magnitude of Clinical Benefit Scale (ESMO-MCBS) threshold rules
      Urania Dafni, Dimitris Karlis, Xanthi Pedeli, Jan Bogaerts, George Pentheroudakis, Josep Tabernero, Christoph C Zielinski, Martine J Piccart, Elisabeth G E de Vries, Nicola Jane Latino, Jean-Yves Douillard, Nathan I Cherny
  7. Pelletier, Gilles

    1. Safety and efficacy of intra-arterial hepatic chemotherapy with doxorubicin-loaded nanoparticles in hepatocellular carcinoma
      Philippe Merle, Philippe Camus, Armand Abergel, Georges Philippe Pageaux, Claude Masliah, Jean Pierre Bronowicki, Jean Pierre Zarski, Gilles Pelletier, Mohamed Bouattour, Laetitia Farloux, Etienne Dorval, Gilles verset, Si-Nafa Si-Ahmed, Michel Doffoel, Patrice Couzigou, Julien Taieb, Bérangère Vasseur, Pierre Attali
  8. Pentheroudakis, George

    1. Nivolumab-induced hypothyroidism and selective pituitary insufficiency in a patient with lung adenocarcinoma: a case report and review of the literature
      Myrto Kastrisiou, Fereniki-Lida Kostadima, Aristides Kefas, George Zarkavelis, Nikos Kapodistrias, Evangelos Ntouvelis, Dimitrios Petrakis, Alexandra Papadaki, Amalia Vassou, George Pentheroudakis
    2. Detailed statistical assessment of the characteristics of the ESMO Magnitude of Clinical Benefit Scale (ESMO-MCBS) threshold rules
      Urania Dafni, Dimitris Karlis, Xanthi Pedeli, Jan Bogaerts, George Pentheroudakis, Josep Tabernero, Christoph C Zielinski, Martine J Piccart, Elisabeth G E de Vries, Nicola Jane Latino, Jean-Yves Douillard, Nathan I Cherny
  9. Petrakis, Dimitrios

    1. Nivolumab-induced hypothyroidism and selective pituitary insufficiency in a patient with lung adenocarcinoma: a case report and review of the literature
      Myrto Kastrisiou, Fereniki-Lida Kostadima, Aristides Kefas, George Zarkavelis, Nikos Kapodistrias, Evangelos Ntouvelis, Dimitrios Petrakis, Alexandra Papadaki, Amalia Vassou, George Pentheroudakis
  10. Piccart, Martine J

    1. Detailed statistical assessment of the characteristics of the ESMO Magnitude of Clinical Benefit Scale (ESMO-MCBS) threshold rules
      Urania Dafni, Dimitris Karlis, Xanthi Pedeli, Jan Bogaerts, George Pentheroudakis, Josep Tabernero, Christoph C Zielinski, Martine J Piccart, Elisabeth G E de Vries, Nicola Jane Latino, Jean-Yves Douillard, Nathan I Cherny
  11. Pullenayegum, Eleanor

    1. Do patients with reduced or excellent performance status derive the same clinical benefit from novel systemic cancer therapies? A systematic review and meta-analysis
      Sierra Cheng, Mahin Qureshi, Eleanor Pullenayegum, Adam Haynes, Kelvin KW Chan

Q

  1. Qureshi, Mahin

    1. Do patients with reduced or excellent performance status derive the same clinical benefit from novel systemic cancer therapies? A systematic review and meta-analysis
      Sierra Cheng, Mahin Qureshi, Eleanor Pullenayegum, Adam Haynes, Kelvin KW Chan

R

  1. Reginelli, Alfonso

    1. Clinical outcome of patients with chemorefractory metastatic colorectal cancer treated with trifluridine/tipiracil (TAS-102): a single Italian institution compassionate use programme
      Vincenzo Sforza, Erika Martinelli, Claudia Cardone, Giulia Martini, Stefania Napolitano, Pietro Paolo Vitiello, Pasquale Vitale, Nicoletta Zanaletti, Alfonso Reginelli, Maurizio Di Bisceglie, Tiziana Pia Latiano, Anna Maria Bochicchio, Fabiana Cecere, Francesco Selvaggi, Fortunato Ciardiello, Teresa Troiani
  2. Rettino, Alessandro

    1. Key differences between 13 KRAS mutation detection technologies and their relevance for clinical practice
      James L Sherwood, Helen Brown, Alessandro Rettino, Amelie Schreieck, Graeme Clark, Bart Claes, Bhuwnesh Agrawal, Ria Chaston, Benjamin S G Kong, Paul Choppa, Anders O H Nygren, Ina L Deras, Alexander Kohlmann

S

  1. Sakai, Hiroshi

    1. Continuing EGFR-TKI beyond radiological progression in patients with advanced or recurrent, EGFR mutation-positive non-small-cell lung cancer: an observational study
      Yasushi Goto, Chiharu Tanai, Kiyotaka Yoh, Yukio Hosomi, Hiroshi Sakai, Terufumi Kato, Takayuki Kaburagi, Makoto Nishio, Young Hak Kim, Akira Inoue, Yoshinori Hasegawa, Hiroshi Isobe, Yoshio Tomizawa, Yoshiaki Mori, Koichi Minato, Kazuhiko Yamada, Yasuo Ohashi, Hideo Kunitoh
  2. Saloustros, Emmanouil

    1. The care of adolescents and young adults with cancer: results of the ESMO/SIOPE survey
      Emmanouil Saloustros, Daniel P Stark, Kyriaki Michailidou, Giannis Mountzios, Laurence Brugieres, Fedro Alessandro Peccatori, Svetlana Jezdic, Samira Essiaf, Jean-Yves Douillard, Stefan Bielack
  3. Sapino, Anna

    1. Genotyping tumour DNA in cerebrospinal fluid and plasma of a HER2-positive breast cancer patient with brain metastases
      Giulia Siravegna, Elena Geuna, Benedetta Mussolin, Giovanni Crisafulli, Alice Bartolini, Danilo Galizia, Laura Casorzo, Ivana Sarotto, Maurizio Scaltriti, Anna Sapino, Alberto Bardelli, Filippo Montemurro
  4. Saraiva, Diana P

    1. How many diseases is triple negative breast cancer: the protagonism of the immune microenvironment
      Diana P Saraiva, M Guadalupe Cabral, António Jacinto, Sofia Braga
  5. Sarotto, Ivana

    1. Genotyping tumour DNA in cerebrospinal fluid and plasma of a HER2-positive breast cancer patient with brain metastases
      Giulia Siravegna, Elena Geuna, Benedetta Mussolin, Giovanni Crisafulli, Alice Bartolini, Danilo Galizia, Laura Casorzo, Ivana Sarotto, Maurizio Scaltriti, Anna Sapino, Alberto Bardelli, Filippo Montemurro
  6. Scaltriti, Maurizio

    1. Genotyping tumour DNA in cerebrospinal fluid and plasma of a HER2-positive breast cancer patient with brain metastases
      Giulia Siravegna, Elena Geuna, Benedetta Mussolin, Giovanni Crisafulli, Alice Bartolini, Danilo Galizia, Laura Casorzo, Ivana Sarotto, Maurizio Scaltriti, Anna Sapino, Alberto Bardelli, Filippo Montemurro
  7. Schreieck, Amelie

    1. Key differences between 13 KRAS mutation detection technologies and their relevance for clinical practice
      James L Sherwood, Helen Brown, Alessandro Rettino, Amelie Schreieck, Graeme Clark, Bart Claes, Bhuwnesh Agrawal, Ria Chaston, Benjamin S G Kong, Paul Choppa, Anders O H Nygren, Ina L Deras, Alexander Kohlmann
  8. Schreitmüller, Thomas

    1. Reply to ‘Biosimilars: a position paper of the European Society for Medical Oncology, with particular reference to oncology prescribers’
      Georgios Bakalos, Thomas Schreitmüller
  9. Selvaggi, Francesco

    1. Clinical outcome of patients with chemorefractory metastatic colorectal cancer treated with trifluridine/tipiracil (TAS-102): a single Italian institution compassionate use programme
      Vincenzo Sforza, Erika Martinelli, Claudia Cardone, Giulia Martini, Stefania Napolitano, Pietro Paolo Vitiello, Pasquale Vitale, Nicoletta Zanaletti, Alfonso Reginelli, Maurizio Di Bisceglie, Tiziana Pia Latiano, Anna Maria Bochicchio, Fabiana Cecere, Francesco Selvaggi, Fortunato Ciardiello, Teresa Troiani
  10. Sforza, Vincenzo

    1. Clinical outcome of patients with chemorefractory metastatic colorectal cancer treated with trifluridine/tipiracil (TAS-102): a single Italian institution compassionate use programme
      Vincenzo Sforza, Erika Martinelli, Claudia Cardone, Giulia Martini, Stefania Napolitano, Pietro Paolo Vitiello, Pasquale Vitale, Nicoletta Zanaletti, Alfonso Reginelli, Maurizio Di Bisceglie, Tiziana Pia Latiano, Anna Maria Bochicchio, Fabiana Cecere, Francesco Selvaggi, Fortunato Ciardiello, Teresa Troiani
  11. Sherwood, James L

    1. Key differences between 13 KRAS mutation detection technologies and their relevance for clinical practice
      James L Sherwood, Helen Brown, Alessandro Rettino, Amelie Schreieck, Graeme Clark, Bart Claes, Bhuwnesh Agrawal, Ria Chaston, Benjamin S G Kong, Paul Choppa, Anders O H Nygren, Ina L Deras, Alexander Kohlmann
  12. Si-Ahmed, Si-Nafa

    1. Safety and efficacy of intra-arterial hepatic chemotherapy with doxorubicin-loaded nanoparticles in hepatocellular carcinoma
      Philippe Merle, Philippe Camus, Armand Abergel, Georges Philippe Pageaux, Claude Masliah, Jean Pierre Bronowicki, Jean Pierre Zarski, Gilles Pelletier, Mohamed Bouattour, Laetitia Farloux, Etienne Dorval, Gilles verset, Si-Nafa Si-Ahmed, Michel Doffoel, Patrice Couzigou, Julien Taieb, Bérangère Vasseur, Pierre Attali
  13. Siravegna, Giulia

    1. Genotyping tumour DNA in cerebrospinal fluid and plasma of a HER2-positive breast cancer patient with brain metastases
      Giulia Siravegna, Elena Geuna, Benedetta Mussolin, Giovanni Crisafulli, Alice Bartolini, Danilo Galizia, Laura Casorzo, Ivana Sarotto, Maurizio Scaltriti, Anna Sapino, Alberto Bardelli, Filippo Montemurro
  14. Stark, Daniel P

    1. The care of adolescents and young adults with cancer: results of the ESMO/SIOPE survey
      Emmanouil Saloustros, Daniel P Stark, Kyriaki Michailidou, Giannis Mountzios, Laurence Brugieres, Fedro Alessandro Peccatori, Svetlana Jezdic, Samira Essiaf, Jean-Yves Douillard, Stefan Bielack

T

  1. Tabernero, Josep

    1. Detailed statistical assessment of the characteristics of the ESMO Magnitude of Clinical Benefit Scale (ESMO-MCBS) threshold rules
      Urania Dafni, Dimitris Karlis, Xanthi Pedeli, Jan Bogaerts, George Pentheroudakis, Josep Tabernero, Christoph C Zielinski, Martine J Piccart, Elisabeth G E de Vries, Nicola Jane Latino, Jean-Yves Douillard, Nathan I Cherny
  2. Taieb, Julien

    1. Safety and efficacy of intra-arterial hepatic chemotherapy with doxorubicin-loaded nanoparticles in hepatocellular carcinoma
      Philippe Merle, Philippe Camus, Armand Abergel, Georges Philippe Pageaux, Claude Masliah, Jean Pierre Bronowicki, Jean Pierre Zarski, Gilles Pelletier, Mohamed Bouattour, Laetitia Farloux, Etienne Dorval, Gilles verset, Si-Nafa Si-Ahmed, Michel Doffoel, Patrice Couzigou, Julien Taieb, Bérangère Vasseur, Pierre Attali
  3. Tanai, Chiharu

    1. Continuing EGFR-TKI beyond radiological progression in patients with advanced or recurrent, EGFR mutation-positive non-small-cell lung cancer: an observational study
      Yasushi Goto, Chiharu Tanai, Kiyotaka Yoh, Yukio Hosomi, Hiroshi Sakai, Terufumi Kato, Takayuki Kaburagi, Makoto Nishio, Young Hak Kim, Akira Inoue, Yoshinori Hasegawa, Hiroshi Isobe, Yoshio Tomizawa, Yoshiaki Mori, Koichi Minato, Kazuhiko Yamada, Yasuo Ohashi, Hideo Kunitoh
  4. Teng, Gao-Jun

    1. Palliative treatment with radiation-emitting metallic stents in unresectable Bismuth type III or IV hilar cholangiocarcinoma
      Jian Lu, Jin-He Guo, Hai-Dong Zhu, Guang-Yu Zhu, Yong Wang, Qi Zhang, Li Chen, Chao Wang, Tian-Fan Pan, Gao-Jun Teng
  5. Tocchetti, Carlo Gabriele

    1. Cardiotoxicity of immune checkpoint inhibitors
      Gilda Varricchi, Maria Rosaria Galdiero, Giancarlo Marone, Gjada Criscuolo, Maria Triassi, Domenico Bonaduce, Gianni Marone, Carlo Gabriele Tocchetti
  6. Tomizawa, Yoshio

    1. Continuing EGFR-TKI beyond radiological progression in patients with advanced or recurrent, EGFR mutation-positive non-small-cell lung cancer: an observational study
      Yasushi Goto, Chiharu Tanai, Kiyotaka Yoh, Yukio Hosomi, Hiroshi Sakai, Terufumi Kato, Takayuki Kaburagi, Makoto Nishio, Young Hak Kim, Akira Inoue, Yoshinori Hasegawa, Hiroshi Isobe, Yoshio Tomizawa, Yoshiaki Mori, Koichi Minato, Kazuhiko Yamada, Yasuo Ohashi, Hideo Kunitoh
  7. Triassi, Maria

    1. Cardiotoxicity of immune checkpoint inhibitors
      Gilda Varricchi, Maria Rosaria Galdiero, Giancarlo Marone, Gjada Criscuolo, Maria Triassi, Domenico Bonaduce, Gianni Marone, Carlo Gabriele Tocchetti
  8. Troiani, Teresa

    1. Clinical outcome of patients with chemorefractory metastatic colorectal cancer treated with trifluridine/tipiracil (TAS-102): a single Italian institution compassionate use programme
      Vincenzo Sforza, Erika Martinelli, Claudia Cardone, Giulia Martini, Stefania Napolitano, Pietro Paolo Vitiello, Pasquale Vitale, Nicoletta Zanaletti, Alfonso Reginelli, Maurizio Di Bisceglie, Tiziana Pia Latiano, Anna Maria Bochicchio, Fabiana Cecere, Francesco Selvaggi, Fortunato Ciardiello, Teresa Troiani

V

  1. Varricchi, Gilda

    1. Cardiotoxicity of immune checkpoint inhibitors
      Gilda Varricchi, Maria Rosaria Galdiero, Giancarlo Marone, Gjada Criscuolo, Maria Triassi, Domenico Bonaduce, Gianni Marone, Carlo Gabriele Tocchetti
  2. Vasseur, Bérangère

    1. Safety and efficacy of intra-arterial hepatic chemotherapy with doxorubicin-loaded nanoparticles in hepatocellular carcinoma
      Philippe Merle, Philippe Camus, Armand Abergel, Georges Philippe Pageaux, Claude Masliah, Jean Pierre Bronowicki, Jean Pierre Zarski, Gilles Pelletier, Mohamed Bouattour, Laetitia Farloux, Etienne Dorval, Gilles verset, Si-Nafa Si-Ahmed, Michel Doffoel, Patrice Couzigou, Julien Taieb, Bérangère Vasseur, Pierre Attali
  3. Vassou, Amalia

    1. Nivolumab-induced hypothyroidism and selective pituitary insufficiency in a patient with lung adenocarcinoma: a case report and review of the literature
      Myrto Kastrisiou, Fereniki-Lida Kostadima, Aristides Kefas, George Zarkavelis, Nikos Kapodistrias, Evangelos Ntouvelis, Dimitrios Petrakis, Alexandra Papadaki, Amalia Vassou, George Pentheroudakis
  4. Vitale, Pasquale

    1. Clinical outcome of patients with chemorefractory metastatic colorectal cancer treated with trifluridine/tipiracil (TAS-102): a single Italian institution compassionate use programme
      Vincenzo Sforza, Erika Martinelli, Claudia Cardone, Giulia Martini, Stefania Napolitano, Pietro Paolo Vitiello, Pasquale Vitale, Nicoletta Zanaletti, Alfonso Reginelli, Maurizio Di Bisceglie, Tiziana Pia Latiano, Anna Maria Bochicchio, Fabiana Cecere, Francesco Selvaggi, Fortunato Ciardiello, Teresa Troiani
  5. Vitiello, Pietro Paolo

    1. Clinical outcome of patients with chemorefractory metastatic colorectal cancer treated with trifluridine/tipiracil (TAS-102): a single Italian institution compassionate use programme
      Vincenzo Sforza, Erika Martinelli, Claudia Cardone, Giulia Martini, Stefania Napolitano, Pietro Paolo Vitiello, Pasquale Vitale, Nicoletta Zanaletti, Alfonso Reginelli, Maurizio Di Bisceglie, Tiziana Pia Latiano, Anna Maria Bochicchio, Fabiana Cecere, Francesco Selvaggi, Fortunato Ciardiello, Teresa Troiani

W

  1. Wang, Chao

    1. Palliative treatment with radiation-emitting metallic stents in unresectable Bismuth type III or IV hilar cholangiocarcinoma
      Jian Lu, Jin-He Guo, Hai-Dong Zhu, Guang-Yu Zhu, Yong Wang, Qi Zhang, Li Chen, Chao Wang, Tian-Fan Pan, Gao-Jun Teng
  2. Wang, Yong

    1. Palliative treatment with radiation-emitting metallic stents in unresectable Bismuth type III or IV hilar cholangiocarcinoma
      Jian Lu, Jin-He Guo, Hai-Dong Zhu, Guang-Yu Zhu, Yong Wang, Qi Zhang, Li Chen, Chao Wang, Tian-Fan Pan, Gao-Jun Teng

Y

  1. Yamada, Kazuhiko

    1. Continuing EGFR-TKI beyond radiological progression in patients with advanced or recurrent, EGFR mutation-positive non-small-cell lung cancer: an observational study
      Yasushi Goto, Chiharu Tanai, Kiyotaka Yoh, Yukio Hosomi, Hiroshi Sakai, Terufumi Kato, Takayuki Kaburagi, Makoto Nishio, Young Hak Kim, Akira Inoue, Yoshinori Hasegawa, Hiroshi Isobe, Yoshio Tomizawa, Yoshiaki Mori, Koichi Minato, Kazuhiko Yamada, Yasuo Ohashi, Hideo Kunitoh
  2. Yoh, Kiyotaka

    1. Continuing EGFR-TKI beyond radiological progression in patients with advanced or recurrent, EGFR mutation-positive non-small-cell lung cancer: an observational study
      Yasushi Goto, Chiharu Tanai, Kiyotaka Yoh, Yukio Hosomi, Hiroshi Sakai, Terufumi Kato, Takayuki Kaburagi, Makoto Nishio, Young Hak Kim, Akira Inoue, Yoshinori Hasegawa, Hiroshi Isobe, Yoshio Tomizawa, Yoshiaki Mori, Koichi Minato, Kazuhiko Yamada, Yasuo Ohashi, Hideo Kunitoh

Z

  1. Zanaletti, Nicoletta

    1. Clinical outcome of patients with chemorefractory metastatic colorectal cancer treated with trifluridine/tipiracil (TAS-102): a single Italian institution compassionate use programme
      Vincenzo Sforza, Erika Martinelli, Claudia Cardone, Giulia Martini, Stefania Napolitano, Pietro Paolo Vitiello, Pasquale Vitale, Nicoletta Zanaletti, Alfonso Reginelli, Maurizio Di Bisceglie, Tiziana Pia Latiano, Anna Maria Bochicchio, Fabiana Cecere, Francesco Selvaggi, Fortunato Ciardiello, Teresa Troiani
  2. Zarkavelis, George

    1. Nivolumab-induced hypothyroidism and selective pituitary insufficiency in a patient with lung adenocarcinoma: a case report and review of the literature
      Myrto Kastrisiou, Fereniki-Lida Kostadima, Aristides Kefas, George Zarkavelis, Nikos Kapodistrias, Evangelos Ntouvelis, Dimitrios Petrakis, Alexandra Papadaki, Amalia Vassou, George Pentheroudakis
  3. Zarski, Jean Pierre

    1. Safety and efficacy of intra-arterial hepatic chemotherapy with doxorubicin-loaded nanoparticles in hepatocellular carcinoma
      Philippe Merle, Philippe Camus, Armand Abergel, Georges Philippe Pageaux, Claude Masliah, Jean Pierre Bronowicki, Jean Pierre Zarski, Gilles Pelletier, Mohamed Bouattour, Laetitia Farloux, Etienne Dorval, Gilles verset, Si-Nafa Si-Ahmed, Michel Doffoel, Patrice Couzigou, Julien Taieb, Bérangère Vasseur, Pierre Attali
  4. Zhang, Qi

    1. Palliative treatment with radiation-emitting metallic stents in unresectable Bismuth type III or IV hilar cholangiocarcinoma
      Jian Lu, Jin-He Guo, Hai-Dong Zhu, Guang-Yu Zhu, Yong Wang, Qi Zhang, Li Chen, Chao Wang, Tian-Fan Pan, Gao-Jun Teng
  5. Zhu, Guang-Yu

    1. Palliative treatment with radiation-emitting metallic stents in unresectable Bismuth type III or IV hilar cholangiocarcinoma
      Jian Lu, Jin-He Guo, Hai-Dong Zhu, Guang-Yu Zhu, Yong Wang, Qi Zhang, Li Chen, Chao Wang, Tian-Fan Pan, Gao-Jun Teng
  6. Zhu, Hai-Dong

    1. Palliative treatment with radiation-emitting metallic stents in unresectable Bismuth type III or IV hilar cholangiocarcinoma
      Jian Lu, Jin-He Guo, Hai-Dong Zhu, Guang-Yu Zhu, Yong Wang, Qi Zhang, Li Chen, Chao Wang, Tian-Fan Pan, Gao-Jun Teng
  7. Zielinski, Christoph C

    1. Detailed statistical assessment of the characteristics of the ESMO Magnitude of Clinical Benefit Scale (ESMO-MCBS) threshold rules
      Urania Dafni, Dimitris Karlis, Xanthi Pedeli, Jan Bogaerts, George Pentheroudakis, Josep Tabernero, Christoph C Zielinski, Martine J Piccart, Elisabeth G E de Vries, Nicola Jane Latino, Jean-Yves Douillard, Nathan I Cherny